Abstract
To the Editor: The number of melanocytic nevi is one of the strongest risk factors for melanoma,1 yet the reasons for the interpersonal variability in this number are largely unknown. Both nevi and melanoma show somatic mutations in the RAS pathway components, most commonly in BRAF.2 Germline mutations in these same genes cause a group of developmental syndromes termed RASopathies,3 some of which characteristically display melanocytic nevi.4 However, the effects of germline RAS pathway mutations on the number of nevi are poorly understood.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
